AKT1 and metabolic dysfunction-associated steatotic liver disease: Some studies have demonstrated that during the development of NAFLD, autophagy is inhibited by the PI3K/AKT signaling pathway via both short-term and long-term regulation mechanisms (Mao et al., 2016).